NCT03791216View on ClinicalTrials.gov

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

June 18, 2025

Study Completion Date

June 18, 2025

Conditions
Psoriasis
Interventions
OTHER

Fasting blood draw for lipid assessments

Fasting blood draw for lipid assessments

Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
collaborator

National Psoriasis Foundation

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Northwestern University

OTHER

NCT03791216 - Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment | Biotech Hunter | Biotech Hunter